Zusammenfassung
Die WHO-Klassifikation von 2004 der Nierentumoren unterscheidet bei den neuroendokrinen Tumoren u. a. das primäre Karzinoid und das primäre neuroendokrine Karzinom der Niere. Es handelt sich dabei um sehr seltene Tumoren. Bisher wurden etwa 100 primäre Karzinoide der Niere beschrieben. Die Histogenese der Nierenkarzinoide ist unklar, da in der Niere des Erwachsenen keine neuroendokrinen Zellen nachweisbar sind. Das histologische Bild der primären Nierenkarzinoide ähnelt denen der Karzinoide in anderen anatomischen Lokalisationen. Häufig werden Karzinoide der Niere fehldiagnostiziert und für papilläre Nierenzellkarzinome, mesonephrische Tumoren, Wilms-Tumoren oder undifferenzierte Karzinome gehalten. Obwohl es sich bei den primären Karzinoiden der Niere um einen Tumor von niedrigem Malignitätspotenzial handelt, wird häufig eine Metastasierung beobachtet. Dies betrifft v. a. Tumoren mit erhöhter Mitoserate (> 2 Mitosen/10 „high power field“ [HPF]). Es wird vorgeschlagen, den Begriff „primäres Karzinoid der Niere“ zu verlassen. Eine künftige WHO-Klassifikation der neuroendokrinen Tumoren sollte sich an Empfehlungen bei anderen Organen orientieren und zwischen neuroendokrinen Tumoren und neuroendokrinen Karzinomen der Niere unterscheiden.
Abstract
The 2004 World Health Organization (WHO) classification of renal cancer includes renal carcinoid and neuroendocrine cancer of the kidneys in the group of primary renal neuroendocrine tumors. The histological features of primary renal carcinoids are similar to those of neuroendocrine tumors found in other anatomical locations. Primary carcinoid tumors of the kidneys are frequently misdiagnosed as other kidney cancers, such as papillary renal cell carcinoma, mesonephric tumors, Wilms tumor (WT) and undifferentiated carcinoma. Immunohistochemical staining results are consistent with the diagnosis of a neuroendocrine tumor with immunoreactivity for synaptophysin, chromogranin, CD56, and neuron-specific enolase (NSE). Positive expression of CD99 can also be seen. There is mainly absence of WT1, cytokeratin 7, cytokeratin 20, thyroid transcription factor (TTF1) and LCA, ruling out most other differential diagnoses. Renal carcinoid tumors are regarded as low-grade neuroendocrine tumors; however, many studies have demonstrated metastatic disease in patients with renal carcinoid tumors. The prognostic value of histological parameters is uncertain. Some studies have correlated poor patient prognosis with increased mitotic activity, presence of necrosis and cytological atypia. Cases with higher mitotic rates of > 2 mitoses/10 high power fields (HPF) developed metastases more frequently; therefore, the WHO classification of neuroendocrine tumors used in other organs is recommended for primary renal carcinoid tumors.
Literatur
Korkmaz T, Seber S, Yavuzer D, Gumus M, Turhal NS (2013) Primary renal carcinoid: treatment and prognosis. Crit Rev Oncol Hematol 87(3):256–264
Aung PP, Killian K, Poropatich CO, Linehan WM, Merino MJ (2013) Primary neuroendocrine tumors of the kidney: morphological and molecular alterations of an uncommon malignancy. Hum Pathol 44(5):873–880
Canacci AM, MacLennan GT (2008) Carcinoid tumor of the kidney. J Urol 180(5):2193
Huettner PC, Bird DJ, Chang YC, Seiler MW (1991) Carcinoid tumor of the kidney with morphologic and immunohistochemical profile of a hindgut endocrine tumor: report of a case. Ultrastruct Pathol 15(6):655–661
Unger PD, Russell A, Thung SN, Gordon RE (1990) Primary renal carcinoid. Arch Pathol Lab Med 114(1):68–71
Resnick ME, Unterberger H, McLoughlin PT (1966) Renal carcinoid producing the carcinoid syndrome. Med Times 94(8):895–896
Baydar DE, Tasar C (2011) Carcinoid tumor in the urinary bladder: unreported features. Am J Surg Pathol 35(11):1754–1757
Guy L, Begin LR, Oligny LL, Brock GB, Chevalier S, Aprikian AG (1999) Searching for an intrinsic neuroendocrine cell in the kidney. An immunohistochemical study of the fetal, infantile and adult kidney. Pathol Res Pract 195(1):25–30
van den Berg E, Gouw AS, Oosterhuis JW, Storkel S, Dijkhuizen T, Mensink HJ, de Jong B (1995) Carcinoid in a horseshoe kidney. Morphology, immunohistochemistry, and cytogenetics. Cancer Genet Cytogenet 84(2):95–98
Fetissof F, Benatre A, Dubois MP, Lanson Y, Arbeille BB, Jobard P (1984) Carcinoid tumor occurring in a teratoid malformation of the kidney. An immunohistochemical study. Cancer 54(10):2305–2308
Eble J, Sauter G, Epstein J, Sesterhenn I (2004) Tumours of the kidney. Tumours of the urinary system and male genital organs. IARC Press, Lyon
Murali R, Kneale K, Lalak N, Delprado W (2006) Carcinoid tumors of the urinary tract and prostate. Arch Pathol Lab Med 130(11):1693–1706
Romero FR, Rais-Bahrami S, Permpongkosol S, Fine SW, Kohanim S, Jarrett TW (2006) Primary carcinoid tumors of the kidney. J Urol 176(6 Pt 1):2359–2366
Krishnan B, Truong LD, Saleh G, Sirbasku DM, Slawin KM (1997) Horseshoe kidney is associated with an increased relative risk of primary renal carcinoid tumor. J Urol 157(6):2059–2066
Takeshima Y, Inai K, Yoneda K (1996) Primary carcinoid tumor of the kidney with special reference to its histogenesis. Pathol Int 46(11):894–900
Motta L, Candiano G, Pepe P, Panella P, Galia A, Aragona F (2004) Neuroendocrine tumor in a horseshoe kidney. Case report and updated follow-up of cases reported in the literature. Urol Int 73(4):361–364
Shibata R, Okita H, Shimoda M, Asakura H, Murai M, Sakamoto M, Hata J (2003) Primary carcinoid tumor in a polycystic kidney. Pathol Int 53(5):317–322
Kojiro M, Ohishi H, Isobe H (1976) Carcinoid tumor occurring in cystic teratoma of the kidney: a case report. Cancer 38(4):1636–1640
Armah HB, Parwani AV, Perepletchikov AM (2009) Synchronous primary carcinoid tumor and primary adenocarcinoma arising within mature cystic teratoma of horseshoe kidney: a unique case report and review of the literature. Diagn Pathol 4:17.
Jeung JA, Cao D, Selli BW, Clapp WL, Oliai BR, Parwani AV, Allan RW (2011) Primary renal carcinoid tumors: clinicopathologic features of 9 cases with emphasis on novel immunohistochemical findings. Hum Pathol 42(10):1554–1561
Raslan WF, Ro JY, Ordonez NG, Amin MB, Troncoso P, Sella A, Ayala AG (1993) Primary carcinoid of the kidney. Immunohistochemical and ultrastructural studies of five patients. Cancer 72(9):2660–2666
Hannah J, Lippe B, Lai-Goldman M, Bhuta S (1988) Oncocytic carcinoid of the kidney associated with periodic Cushing’s syndrome. Cancer 61(10):2136–2140
Hamilton I, Reis L, Bilimoria S, Long RG (1980) A renal vipoma. Br Med J 281(6251):1323–1324
Mazzucchelli R, Morichetti D, Lopez-Beltran A, Cheng L, Scarpelli M, Kirkali Z, Montironi R (2009) Neuroendocrine tumours of the urinary system and male genital organs: clinical significance. BJU Int 103(11):1464–1470
Hansel DE, Epstein JI, Berbescu E, Fine SW, Young RH, Cheville JC (2007) Renal carcinoid tumor: a clinicopathologic study of 21 cases. Am J Surg Pathol 31(10):1539–1544
Acconcia A, Miracco C, Mattei FM, deSanti MM, Del VMT, Luzi P (1988) Primary carcinoid tumor of kidney. light and electron microscopy, and immunohistochemical study. Urology 31(6):517–520
Tal R, Lask DM, Livne PM (2003) Metastatic renal carcinoid: case report and review of the literature. Urology 61(4):838
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
H. Moch gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Additional information
Schwerpunktherausgeber
W. Saeger, Hamburg
Rights and permissions
About this article
Cite this article
Moch, H. Neuroendokrine Tumoren der Niere. Pathologe 36, 278–282 (2015). https://doi.org/10.1007/s00292-015-0018-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00292-015-0018-y